| Range: | 4.0-20.0 | Vol Avg: | 66331 | Last Div: | 0 | Changes: | -0.15 |
| Beta: | 0.55 | Cap: | 0.27B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Apr 28 2021 | Empoloyees: | 146 | ||
| CUSIP: | CIK: | 0001857190 | ISIN: | BE0974358906 | Country: | BE | |
| CEO: | Mr. Olivier Taelman | Website: | https://www.nyxoah.com | ||||
NYXH 0.00 Stock Price Nyxoah S.A.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Stock Details
Neutral 0.00
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36 th Annual Healthcare Conference...
globenewswire.com·Wed Nov 20 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow